CL-SCIENCES
DEAD

Serial Number

76248462

Owner

Celestar Lexico-Sciences, Inc.

Attorney

Kdushal R. Odedra

Filing Date

Apr 25, 2001

Add to watchlist:

No watchlists yet
View on USPTO

CL-SCIENCES Trademark

Serial Number: 76248462 • Registration: 2692240

CL-SCIENCES is a trademark filed by Celestar Lexico-Sciences, Inc. on April 25, 2001. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Celestar Lexico-Sciences, Inc. (6 trademarks)

D-17, Makuhari-Techno-Garden
Chiba-shi, Chiba , JP

Entity Type: 03

Trademark Details

Filing Date

April 25, 2001

Registration Date

March 4, 2003

Published for Opposition

December 10, 2002

Cancellation Date

October 10, 2009

Goods & Services

Computer programs for use in analyzing and visualizing nucleic acid, protein, and phage information and expression; for use in database management, integration and manipulation; for use in characterization of nucleic acid and protein information; for use in analyzing chemical structure and activity information; for use in acquisition and interrogation of clinical, pathological, diagnostic, genetic, genomic and biochemical data; for use in clinical trial design and management; for use in text and pattern recognition; for storage, retrieval and analysis of life sciences literature; for use in managing robot function; for use in processing toxicological and pharmacological information; for laboratory instrument control; for use in control of sample input to mass spectrometers; for use in spectral analysis; prerecorded CD-ROMs featuring databases containing life sciences information; pre-configured microprocessors for analysis and storage of life sciences information; computer programs for use in the management, storage, retrieval, and analysis for data in the discovery and development of diagnostic, prognostic, and therapeutic medical products; for use in identifying and characterizing proteins; for use in controlling mass spectrometers; for use in spectral analysis; for use in controlling affinity capture optical biosensors; for use in analyzing and characterizing plasmon resonance; for use in controlling liquid chromatography instruments; for use in analyzing chromatograms; for use in controlling microfluidics; for use in controlling single-dimension and multi-dimensional electrophoresis and visualizing and analyzing electrophoretic results; for use in protein analysis and spectral processing; for use in analyzing, managing, and visualizing nucleic acid and amino acid sequences

Medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; computer services, namely, providing databases featuring life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, namely, providing databases featuring life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 10, 2009 C8..
CASE FILE IN TICRS
Apr 2, 2008 CFIT
REGISTERED-PRINCIPAL REGISTER
Mar 4, 2003 R.PR
PUBLISHED FOR OPPOSITION
Dec 10, 2002 PUBO
NOTICE OF PUBLICATION
Nov 20, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2002 CNSA
Sec. 1(B) CLAIM DELETED
Aug 1, 2002 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2002 CRFA
PAPER RECEIVED
Aug 1, 2002 MAIL
LETTER OF SUSPENSION MAILED
Apr 5, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2002 CRFA
NON-FINAL ACTION MAILED
Aug 10, 2001 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2001 DOCK